• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞在肝纤维化中的应用:新策略、机制及临床实践

Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice.

作者信息

Zhu Mengmei, Hua Tianzhen, Ouyang Tao, Qian Huofu, Yu Bing

机构信息

Department of Cell Biology, Center for Stem Cell and Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, China.

Department of Gastroenterology, The Second People's Hospital of Taizhou, China.

出版信息

Stem Cells Int. 2021 Aug 10;2021:6546780. doi: 10.1155/2021/6546780. eCollection 2021.

DOI:10.1155/2021/6546780
PMID:34434239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8380491/
Abstract

Liver fibrosis is a common result of most chronic liver diseases, and advanced fibrosis often leads to cirrhosis. Currently, there is no effective treatment for liver cirrhosis except liver transplantation. Therefore, it is important to carry out antifibrosis treatment to reverse liver damage in the early stage of liver fibrosis. Mesenchymal stem cells (MSCs) are the most widely used stem cells in the field of regenerative medicine. The preclinical and clinical research results of MSCs in the treatment of liver fibrosis and cirrhosis show that MSC administration is a promising treatment for liver fibrosis and cirrhosis. MSCs reverse liver fibrosis and increase liver function mainly through differentiation into hepatocytes, immune regulation, secretion of cytokines and other nutritional factors, reduction of hepatocyte apoptosis, and promotion of hepatocyte regeneration. Recently, many studies provided a variety of new methods and strategies to improve the effect of MSCs in the treatment of liver fibrosis. In this review, we summarized the current effective methods and strategies and their potential mechanisms of MSCs in the treatment of liver fibrosis, as well as the current research progress in clinical practice. We expect to achieve complete reversal of liver injury with MSC-based therapy in the future.

摘要

肝纤维化是大多数慢性肝病的常见后果,而晚期纤维化常导致肝硬化。目前,除肝移植外,尚无治疗肝硬化的有效方法。因此,在肝纤维化早期开展抗纤维化治疗以逆转肝损伤具有重要意义。间充质干细胞(MSCs)是再生医学领域应用最广泛的干细胞。MSCs治疗肝纤维化和肝硬化的临床前及临床研究结果表明,输注MSCs是一种有前景的肝纤维化和肝硬化治疗方法。MSCs主要通过分化为肝细胞、免疫调节、分泌细胞因子及其他营养因子、减少肝细胞凋亡和促进肝细胞再生来逆转肝纤维化并改善肝功能。近年来,许多研究提供了多种新方法和策略来提高MSCs治疗肝纤维化的效果。在本综述中,我们总结了目前MSCs治疗肝纤维化的有效方法和策略及其潜在机制,以及当前临床实践中的研究进展。我们期望未来基于MSCs的治疗能够实现肝损伤的完全逆转。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/e9e0a9d66e29/SCI2021-6546780.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/a6e48aa63c23/SCI2021-6546780.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/e63ab39e2d0f/SCI2021-6546780.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/e9e0a9d66e29/SCI2021-6546780.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/a6e48aa63c23/SCI2021-6546780.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/e63ab39e2d0f/SCI2021-6546780.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8380491/e9e0a9d66e29/SCI2021-6546780.003.jpg

相似文献

1
Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice.间充质干细胞在肝纤维化中的应用:新策略、机制及临床实践
Stem Cells Int. 2021 Aug 10;2021:6546780. doi: 10.1155/2021/6546780. eCollection 2021.
2
Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis.间充质干细胞治疗在肝纤维化中的免疫调节作用。
Front Immunol. 2023 Jan 4;13:1096402. doi: 10.3389/fimmu.2022.1096402. eCollection 2022.
3
Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.提高间充质干细胞移植逆转肝纤维化效率的策略。
J Cell Mol Med. 2019 Mar;23(3):1657-1670. doi: 10.1111/jcmm.14115. Epub 2019 Jan 11.
4
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis.间充质干细胞治疗肝纤维化/肝硬化。
Ann Transl Med. 2020 Apr;8(8):562. doi: 10.21037/atm.2020.02.119.
5
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.间充质干细胞治疗肝硬化:现状与未来展望。
World J Gastroenterol. 2015 Sep 28;21(36):10253-61. doi: 10.3748/wjg.v21.i36.10253.
6
Mesenchymal stem cell therapy for liver fibrosis.间充质干细胞治疗肝纤维化
Korean J Intern Med. 2015 Sep;30(5):580-9. doi: 10.3904/kjim.2015.30.5.580. Epub 2015 Aug 27.
7
Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.间充质干细胞治疗肝纤维化的现状与未来展望
J Zhejiang Univ Sci B. 2016;17(11):831-841. doi: 10.1631/jzus.B1600101.
8
Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.简明综述:间充质干细胞治疗急性肝衰竭和肝硬化的治疗潜力。
Stem Cells. 2014 Nov;32(11):2818-23. doi: 10.1002/stem.1818.
9
Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis and : From biological characteristics to therapeutic mechanisms.人脐带间充质干细胞改善肝纤维化:从生物学特性到治疗机制
World J Stem Cells. 2019 Aug 26;11(8):548-564. doi: 10.4252/wjsc.v11.i8.548.
10
Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats.肝细胞生长因子表达间充质干细胞对小体积肝移植大鼠的抗纤维化作用。
Stem Cells Dev. 2010 Jun;19(6):903-14. doi: 10.1089/scd.2009.0254.

引用本文的文献

1
Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells.人脐带间充质干细胞来源的外泌体miR-499a-5p通过靶向ETS1/GPX4介导的肝星状细胞铁死亡减轻肝纤维化。
J Nanobiotechnology. 2025 Mar 19;23(1):222. doi: 10.1186/s12951-025-03291-4.
2
Innovative Strategies for Liver Transplantation: The Role of Mesenchymal Stem Cells and Their Cell-Free Derivatives.创新的肝移植策略:间充质干细胞及其无细胞衍生物的作用。
Cells. 2024 Sep 25;13(19):1604. doi: 10.3390/cells13191604.
3
Efficacy of stem cell therapy in patients with chronic liver disease: an umbrella review of systematic reviews.

本文引用的文献

1
Towards Physiologic Culture Approaches to Improve Standard Cultivation of Mesenchymal Stem Cells.迈向生理文化方法,改善间充质干细胞的标准培养。
Cells. 2021 Apr 13;10(4):886. doi: 10.3390/cells10040886.
2
Functional Properties of Human-Derived Mesenchymal Stem Cell Spheroids: A Meta-Analysis and Systematic Review.人源间充质干细胞球状体的功能特性:一项荟萃分析与系统评价
Stem Cells Int. 2021 Mar 31;2021:8825332. doi: 10.1155/2021/8825332. eCollection 2021.
3
Enhancement of anti-inflammatory and immunomodulatory effects of adipose-derived human mesenchymal stem cells by making uniform spheroid on the new nano-patterned plates.
干细胞疗法对慢性肝病患者的疗效:系统评价的伞状综述
Int J Surg. 2024 Nov 1;110(11):6848-6861. doi: 10.1097/JS9.0000000000001644.
4
Therapeutic potential of exosome derived from hepatocyte growth factor-overexpressing adipose mesenchymal stem cells in TGFβ1-stimulated hepatic stellate cells.肝细胞生长因子过表达脂肪间充质干细胞来源外泌体对转化生长因子β1刺激的肝星状细胞的治疗潜力
Cytotechnology. 2024 Apr;76(2):217-229. doi: 10.1007/s10616-023-00611-0. Epub 2024 Feb 15.
5
Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment.脂肪组织和脐带组织:用于治疗肝纤维化的间充质干细胞的潜在来源。
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101364. doi: 10.1016/j.jceh.2024.101364. Epub 2024 Feb 12.
6
Establishing an hTERT-driven immortalized umbilical cord-derived mesenchymal stem cell line and its therapeutic application in mice with liver failure.建立一种hTERT驱动的永生化脐带间充质干细胞系及其在肝衰竭小鼠中的治疗应用。
J Tissue Eng. 2023 Sep 19;14:20417314231200328. doi: 10.1177/20417314231200328. eCollection 2023 Jan-Dec.
7
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.慢性乙型肝炎病毒感染的免疫反应和治疗靶点:固有和适应性免疫。
Front Cell Infect Microbiol. 2023 Jun 22;13:1206720. doi: 10.3389/fcimb.2023.1206720. eCollection 2023.
8
Adipose-Derived Stromal Cells within a Gelatin Matrix Acquire Enhanced Regenerative and Angiogenic Properties: A Pre-Clinical Study for Application to Chronic Wounds.明胶基质中的脂肪来源基质细胞具有增强的再生和血管生成特性:一项应用于慢性伤口的临床前研究。
Biomedicines. 2023 Mar 22;11(3):987. doi: 10.3390/biomedicines11030987.
9
MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis.MRI/PAI双模态成像引导下对纳米颗粒标记的骨髓间充质干细胞治疗肝硬化的精确追踪
J Clin Transl Hepatol. 2023 Apr 28;11(2):382-392. doi: 10.14218/JCTH.2021.00580. Epub 2022 May 27.
10
Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats.手术植入人脂肪来源干细胞可减轻大鼠实验性肝纤维化。
Mol Med. 2022 Nov 29;28(1):143. doi: 10.1186/s10020-022-00566-6.
通过在新型纳米图案化平板上制作均匀的球体,增强脂肪来源的人骨髓间充质干细胞的抗炎和免疫调节作用。
Biochem Biophys Res Commun. 2021 May 7;552:164-169. doi: 10.1016/j.bbrc.2021.03.026. Epub 2021 Mar 19.
4
Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.人脐带间充质干细胞通过抑制p21活化激酶2上调微小RNA-455-3p来改善肝星状细胞活化和肝纤维化。
Biomed Res Int. 2021 Feb 25;2021:6685605. doi: 10.1155/2021/6685605. eCollection 2021.
5
Increased Mesenchymal Stem Cell Functionalization in Three-Dimensional Manufacturing Settings for Enhanced Therapeutic Applications.三维制造环境中增强间充质干细胞功能化以促进治疗应用
Front Bioeng Biotechnol. 2021 Feb 12;9:621748. doi: 10.3389/fbioe.2021.621748. eCollection 2021.
6
Mesenchymal stem cell spheroids incorporated with collagen and black phosphorus promote osteogenesis of biodegradable hydrogels.掺入胶原蛋白和黑磷的间充质干细胞球促进可生物降解水凝胶的成骨作用。
Mater Sci Eng C Mater Biol Appl. 2021 Feb;121:111812. doi: 10.1016/j.msec.2020.111812. Epub 2020 Dec 28.
7
Mesenchymal Stem Cell Spheroids Embedded in an Injectable Thermosensitive Hydrogel: An In Situ Drug Formation Platform for Accelerated Wound Healing.嵌入可注射热敏水凝胶的间充质干细胞球状体:用于加速伤口愈合的原位药物形成平台。
ACS Biomater Sci Eng. 2020 Sep 14;6(9):5096-5109. doi: 10.1021/acsbiomaterials.0c00988. Epub 2020 Aug 27.
8
Allogeneic mesenchymal stem cell sheet therapy: A new frontier in drug delivery systems.异体间充质干细胞片治疗:药物传递系统的新前沿。
J Control Release. 2021 Feb 10;330:696-704. doi: 10.1016/j.jconrel.2020.12.028. Epub 2020 Dec 19.
9
Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats.人羊膜干细胞可改善肝硬化大鼠的肝微血管功能障碍和门静脉高压。
Liver Int. 2020 Oct;40(10):2500-2514. doi: 10.1111/liv.14610. Epub 2020 Aug 9.
10
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Potential.间充质干细胞衍生的细胞外囊泡及其治疗潜力。
Stem Cells Int. 2020 Aug 24;2020:8825771. doi: 10.1155/2020/8825771. eCollection 2020.